ALLO vs LC · rev $22.0K vs P/E 28, $1.43B cap
Allogene Therapeutics Inc (ALLO) versus LendingClub Corp (LC) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
LendingClub Corp (LC) is a banks - regional company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
LC does not have a complete income-statement cache yet.
ALLO currently screens at market cap $258.1M. LC currently screens at market cap $1.43B and trailing P/E 28.4.
Not investment advice. Open the ALLO and LC stock pages for the full models.
Not investment advice.